A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease

NCT07011771 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
SUSPENDED
Status
31
Enrollment
INDUSTRY
Sponsor class

Stopped Per protocol stopping rule was met for a separate trial for a different disease state and different experimental therapy that utilized a similar technology.

Conditions

Interventions

Sponsor

Capsida Biotherapeutics, Inc.